Biobank Ireland receives funds from several sectors – from industry, business, philanthropists, and from fundraising events. Grants from biopharmaceutical companies (Amgen, Merck-Serono, Lilly, Sanofi-Aventis, Astra Zeneca, MSD, Pfizer, Novartis, GSK, Janssen, Abbvie, Bayer, Roche, Helsinn-Birex) have helped sponsor salaries of dedicated biobank personnel. All stakeholders realise how essential biobanking is for developing new biomarkers and better treatment for future patients, and for providing opportunities for collaborative research, including academic-industry partnerships that will stimulate the economy.
Biobank Ireland Trust does not have the resources to expand and complete the Biobank Network (€10m. over 5 years). Following discussions of costs with Science Foundation Ireland, it is clear that funding must be obtained from both non-governmental sectors as well as government. Furthermore, we agree there must be a commitment to cost recovery and sustainability. However, government funding is essential: the biobank networks of France, Spain, Wales, Canada, and other countries receive government funding. No national network is privately funded or fully sustainable.